A new enterprise combining resources from biotechnology and artificial intelligence aims to find safer and more effective treatments for psychiatric disorders. . . . → Read More: New Company Using A.I. to Discover Mental Health Drugs
|
|||||
|
|
Initial results from a clinical trial show a drug designed to supplement first-line treatments helps reduce symptoms of major depressive disorder. . . . → Read More: Early Results Show Anti-Depressive Drug Effects  Comments are closed  New products  biomedical, biotechnology, clinical trials, life sciences, pharmaceuticals, psychiatric 
A clinical trial is planned to test cannabidiol, or CBD, derived from cannabis as a treatment for hallucinations and delusions among people with Parkinson’s disease. . . . → Read More: Trial to Test CBD for Parkinson’s-Related Psychosis One comment - (Comments are closed) New products biomedical, clinical trials, Europe, life sciences, pharmaceuticals, psychiatric, U.K., university 
A new enterprise based on psychiatric and molecular research at Indiana University is developing precision-medicine diagnostics for pain and mental disease. . . . → Read More: Start-Up Creating Blood Tests, Apps for Mental Disorders Comments are closed Intellectual property, New products biomedical, clinical trials, entrepreneurs, genomics, licensing, life sciences, medical device, psychiatric, university 
A lab studying DNA from past civilizations and the genomics technology company Illumina are investigating remains of ancient peoples for insights into today’s neurological disorders. . . . → Read More: Ancient DNA Studied for Mental Health Clues One comment - (Comments are closed) Joint ventures/collaborations biomedical, engineering, Europe, genomics, life sciences, mathematics, medical device, physical sciences, psychiatric, university 
A company in the U.K. developing automated treatments for phobias using immersive virtual reality is raising £3.2 million ($US 5.1 million) in its first venture funding round. . . . → Read More: Virtual Reality Therapy Company Gains $5.1M in Early Funds Comments are closed Finance, New products behavioral science, biomedical, clinical trials, engineering, entrepreneurs, equity, Europe, investment, licensing, life sciences, medical device, psychiatric, software, U.K., university, venture capital 
A non-invasive device using magnetic waves that penetrate the brain to treat obsessive-compulsive disorder received authorization for sales in the U.S. from the Food and Drug Administration. . . . → Read More: FDA Clears Magnetic Device for Obsessive Compulsive Disorder Comments are closed Regulations biomedical, clinical trials, engineering, FDA, Israel, life sciences, medical device, physical sciences, physics, psychiatric 
A study of leading mobile apps for mental health indicates many apps promote their use with misleading guidance to individuals on the extent and seriousness of psychological conditions. . . . → Read More: Apps Seen Over-Diagnosing Mental Health Conditions 3 comments - (Comments are closed) Regulations Australia, behavioral science, biomedical, medical device, psychiatric, software, university 
Statistical models derived from data in electronic health records and standard questionnaires for depression are shown to better predict a person’s risk of suicide following a doctor’s office or mental health clinic visit. . . . → Read More: New Models Improve Suicide Risk Predictions Comments are closed New products behavioral science, biomedical, health care, mathematics, psychiatric, statistics The Food and Drug Administration approved for the first time in the U.S. a system that combines pills with built-in sensors and a mobile app to track adherence. . . . → Read More: FDA Clears First Sensor-Pill and App System One comment - (Comments are closed) Joint ventures/collaborations, Regulations biomedical, engineering, FDA, life sciences, medical device, pharmaceuticals, physical sciences, psychiatric, software |
||||
|
Copyright © 2019 Technology News and Literature - All Rights Reserved Powered by WordPress & Atahualpa |
|||||